NY S02677 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 3-0)
Status: Introduced on January 24 2023 - 25% progression, died in chamber
Action: 2023-06-07 - SUBSTITUTED BY A463A
Text: Latest bill text (Amended) [HTML]

Summary

Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.

Sponsors


History

DateChamberAction
2023-06-07SenateSUBSTITUTED BY A463A
2023-05-30SenateAMENDED ON THIRD READING 2677A
2023-05-24SenateADVANCED TO THIRD READING
2023-05-23Senate2ND REPORT CAL.
2023-05-22Senate1ST REPORT CAL.1179
2023-01-24SenateREFERRED TO INSURANCE

Same As/Similar To

A00463 (Same As) 2023-12-22 - approval memo.61

New York State Sources


Bill Comments

feedback